Bone marrow transplantation is an example of a highly technical therapy that offers hope to patients with bone marrow failure or various malignancies.
Bone marrow transplantation is much more costly « up-front » but perhaps not more costly long-term than alternative therapies.
Although economic analyses appear relatively simple, interpretation and use can be problematic.
Several economic analyses have identified complications that occur frequently and affect the reported cost-effectiveness of high-dose chemotherapy.
Efforts to reduce the cost of bone marrow transplantation have focused on new strategies to more effectively control these complications.
The introduction of new technologies to speed engraftment, to improve patient selection methods, and the shifting of care to outpatient settings all have resulted in significant reductions in duration of hospital stay, treatment-related mortality, and costs.
More studies of long-term outcomes are needed for transplant and nontransplant treatment options to guide present and future applications of this treatment option.
Mots-clés Pascal : Moelle osseuse, Transplantation, Evaluation, Coût, Complication, Progrès technique, Chimiothérapie, Dose forte, Etude comparative, Article synthèse, Homme, Hémopathie, Chirurgie, Economie santé
Mots-clés Pascal anglais : Bone marrow, Transplantation, Evaluation, Costs, Complication, Technical progress, Chemotherapy, High dose, Comparative study, Review, Human, Hemopathy, Surgery, Health economy
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0437953
Code Inist : 002B27D02. Création : 19/12/1997.